The study found that the inhibition of HSP90 attenuated cardiac hypertrophy in neonatal mouse ventricular cardiomyocytes induced by aortic zonation and phenylephrine, and may be an important target for the treatment of HF [111]. Here, HSP90AA1 is linked to cardiac hypertrophy.